A nonantigenic covalent streptokinase-polyethylene glycol complex with plasminogen activator function.
A series of new, covalent polyethylene glycol (PEG)-streptokinase adducts were synthesized and characterized. PEGs with average molecular weights of 2,000, 4,000, and 5,000 were activated with carbonyldiimidazole and coupled to the protein under standardized reaction conditions. Steady-state kinetic...
Tallennettuna:
| Julkaisussa: | J Clin Invest |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society for Clinical Investigation
1985
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC423508/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3156148/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI111715 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
